Log in

RAC Racura Oncology Ltd ASX · Australia

Racura Oncology (RAC) news

Racura Oncology Ltd is a public biotech or pharmaceutical company listed on ASX under the ticker RAC, recorded under Australia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Racura Oncology news

We have not published a story on Racura Oncology yet. When there is news, it will appear here.

Questions about Racura Oncology

What is the ticker symbol of Racura Oncology?

Racura Oncology Ltd trades under the ticker RAC on ASX.

Where is Racura Oncology listed?

Racura Oncology Ltd is listed on ASX. Our directory also records these other listings: GETTEX:FN3.

Which country or territory is Racura Oncology listed under?

Our directory records Racura Oncology Ltd under Australia.

What does Racura Oncology do?

Our directory classifies Racura Oncology Ltd as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Racura Oncology?

The ISIN recorded for Racura Oncology Ltd is AU000000RAC3.

Does aibio.space cover Racura Oncology?

aibio.space lists Racura Oncology Ltd among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Racura Oncology?

Companies in our directory listed in the same country and business area as Racura Oncology: Island Pharmaceuticals, Syntara, Patrys, Avecho Biotechnology, Vectus Biosystems, Tissue Repair.

Investor discussion: Racura Oncology

Members talk about Racura Oncology (RAC). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open ASX:RAC on TradingView.

Listing details

Racura Oncology Ltd is a public biotech or pharmaceutical company listed on ASX under the ticker RAC, recorded under Australia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Racura Oncology Ltd
Ticker
RAC
Listing
ASX
Country or territory
Australia
Business scope
Pharmaceuticals: Major
ISIN
AU000000RAC3
Other listed symbols
GETTEX:FN3
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.